Tom Spurling – Executive Director – Nova Eye Medical (ASX:EYE) is introducing a comprehensive portfolio of novel glaucoma treatment options which span the entire disease process – enabling physicians to intervene earlier, and more often, in the treatment of glaucoma.
Copyright 2023 – Finance News Network
Source: Finance News Network
04 Sep 2023 - Glen Diemar, Managing Director of Australian Gold and Copper Limited (ASX:AGC), provides an update on the company, discussing drill targets, plans and outlook.
Read More08 Dec 2023 - Stealth Global Holdings reports record FY23 results, driven by efficient consolidation, organic growth, and prudent financial management. CEO Mike Arnold reveals plans for further expansion, M&A, and a commitment to dividends in FY24.
Read More31 Aug 2020 - Sequoia Financial Group Limited (ASX:SEQ) Managing Director & CEO Garry Crole talks about the company's group strategy, outlook, and much improved FY20 results, despite the challenging operating environment.
Read More29 Jan 2021 - Cyclopharm (ASX:CYC) CEO & Managing Director, James McBrayer talks about its recent cap raising to support rapid USA commercialisation for Technegas following USFDA approval targeted in Q2 2021.
Read More01 Apr 2022 - Lepidico Limited (ASX:LPD) Managing Director Joe Walsh discusses the progress of the company's Karibib lithium operations and Abu Dhabi processing plant, potential capital raisings and offtake agreements.
Read More14 Aug 2025 - CEO and Managing Director Mark Freeman and Portfolio Manager David Grace discuss the FY25 full-year results of Australian Foundation Investment Company (ASX:AFI).
Read More21 Mar 2021 - Elixinol Global (ASX:EXL) CEO, Oliver Horn talks about its proposed acquisition of CannaCare Health GmbH (CannaCare) one of Germany’s leading CBD (Cannabidiol) brands following the down scheduling of CBD in Europe late last year in what the Company sees as highly strategic opportunity and important pathway to profitability.
Read More10 Oct 2023 - Andrew Radonjic - Managing Director - Venture Minerals (ASX:VMS) is dedicated to discovering and developing world-class mineral deposits to meet global demand for critical minerals vital to the green energy transition.
Read MoreWhy the metal deserves a long-term place in diversified portfolios
Read More29 Mar 2021 - Telix Pharmaceuticals Limited (ASX:TLX) Chief Business Officer Dr David Cade talks about the company's clinical programs, including approvals, partnerships and significant value events anticipated in 2021.
Read More
